Form 8-K - Current report:
SEC Accession No. 0001564590-15-007723
Filing Date
2015-09-03
Accepted
2015-09-03 16:30:58
Documents
2
Period of Report
2015-09-03
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abio-8k_20150903.htm 8-K 32651
2 EX-3.1 abio-ex31_74.htm EX-3.1 12390
  Complete submission text file 0001564590-15-007723.txt   46398
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 151092337
SIC: 2835 In Vitro & In Vivo Diagnostic Substances